Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 4/20 | 0.53 |
| ▸ | DRD3 | P35462 | 4/20 | 0.53 |
| ▸ | DRD2 | P14416 | 3/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.51 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (Chloromethyl)Benzene SCHEMBL17022934 | 0.94 | KCNH2 (0.59) | OPRM1DRD3DRD2OPRD1OPRK1 | |
| (Chloromethyl)Benzene SCHEMBL10767165 | 0.92 | KCNH2 (0.62) | OPRM1DRD3DRD2OPRD1OPRK1 | |
| SCHEMBL8666908 | 0.90 | MAPT (0.52) | OPRM1DRD3DRD2OPRD1OPRK1 | |
| (Chloromethyl)Benzene SCHEMBL7216279 | 0.88 | DRD3 (0.50) | OPRM1DRD3DRD2OPRD1OPRK1 | |
| (Chloromethyl)Benzene SCHEMBL27477517 | 0.85 | SIGMAR1 (0.50) | KCNH2MEN1KMT2A | |
| SCHEMBL6947636 | 0.82 | OPRM1 (0.73) | OPRM1DRD3DRD2OPRD1OPRK1 | |
| SCHEMBL5879246 | 0.82 | OPRM1 (0.73) | OPRM1DRD3DRD2OPRD1OPRK1 | |
| SCHEMBL12540441 | 0.82 | OPRM1 (0.74) | OPRM1DRD3DRD2OPRD1OPRK1 | |
| Benzyl Bromide SCHEMBL457700 | 0.82 | TRPA1 (0.58) | OPRM1DRD3DRD2OPRD1OPRK1 | |
| SCHEMBL9720308 | 0.82 | MAPT (0.58) | OPRM1DRD3DRD2OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117258767-B | Novel psychoactive substance adsorbent and application thereof | 西南政法大学 | 2026-05-19 | — | — | CN | claimed |
| CN-119555859-A | High-sensitivity high-flux identification method for saccharide compounds based on chlorine enhanced ionization | 北京大学 | 2025-03-04 | — | — | CN | claimed |
| CN-119431161-A | Synthesis method of mebeverine hydrochloride | 河北广祥制药有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119281376-A | Molecular sieve catalyst, preparation method thereof and application thereof in preparation of substituted aromatic hydrocarbon compounds | 浙江新和成股份有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-118791342-A | Method for optimizing TATB performance based on curing effect | 西南科技大学 | 2024-10-18 | — | — | CN | claimed |
| WO-2023159094-A2 | PROCESS OF MAKING 3α-HYDROXY-3β-METHOXYMETHYL-21-(1'- IMIDAZOLYL)-5α-PREGNAN-20-ONE | PRAXIS PRECISION MEDICINES, INC. (US) | 2023-08-24 | — | — | WO | claimed |
| US-11719695-B2 | Immunoassay method to prevent inhibition of antigen-antibody binding interactions in mucosal fluids | NH FOODS LTD (JP) | 2023-08-08 | — | — | US | claimed |
| US-20190127311-A1 | C-HALOGEN BOND FORMATION | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2019-05-02 | — | — | US | claimed |
| US-10196341-B2 | C-halogen bond formation | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2019-02-05 | — | — | US | claimed |
| US-20140249329-A1 | C-HALOGEN BOND FORMATION | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2014-09-04 | — | — | US | claimed |
| EP-1841739-B1 | PROCESS FOR PRODUCING 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL] PIPERIDINE OR SALT THEREOF VIA NOVEL INTERMEDIATE | JUBILANT ORGANOSYS LTD (IN) | 2013-02-20 | — | — | EP | claimed |
| US-8124783-B2 | Process for producing 1-benzyl-4-[5,6-dimethoxy-1-indanon-2-yl)methyl] piperidine or its salt thereof via novel intermediate | JUBILANT ORGANOSYS LIMITED (IN) | 2012-02-28 | — | — | US | claimed |
| WO-2011030213-A8 | IMPROVED PROCESS FOR THE PREPARATION OF 7-(4-BROMOBUTOXY) 3,4-DIHYDROCARBOSTYRIL, A PRECURSOR OF ARIPIPRAZOLE | JUBILANT LIFE SCIENCES LIMITED (IN) | 2011-05-19 | — | — | WO | claimed |
| WO-2011030213-A1 | IMPROVED PROCESS FOR THE PREPARATION OF 7.(4-BROMOBUTOXY) 3,4-DIHYDROCARBOSTYRIL, A PRECURSOR OF ARIPIPRAZOLE | JUBILANT ORGANOSYS LIMITED (IN) | 2011-03-17 | — | — | WO | claimed |
| US-20090137812-A1 | PROCESS FOR PRODUCING 1-BENZYL-4-[5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE OR ITS SALT THEREOF VIA NOVEL INTERMEDIATE | JUBILANT ORGANOSYS LIMITED (IN) | 2009-05-28 | — | — | US | claimed |
| EP-1841739-A4 | PROCESS FOR PRODUCING 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON2-YL)METHYL] PIPERIDINE OR ITS SALT THEREOF VIA NOVEL INTERMEDIATE | JUBILANT ORGANOSYS LTD (IN) | 2008-10-01 | — | — | EP | claimed |
| US-7390927-B2 | Process for preparing 3-aminophenylacetylenes | FUJILFILM CORPORATION (JP) | 2008-06-24 | — | — | US | claimed |
| EP-1841739-A1 | PROCESS FOR PRODUCING 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON2-YL)METHYL] PIPERIDINE OR ITS SALT THEREOF VIA NOVEL INTERMEDIATE | Jubilant Organosys Limited (IN) | 2007-10-10 | — | — | EP | claimed |
| US-20060224016-A1 | Process for preparing 3-aminophenylacetylenes | FUJI PHOTO FILM CO., LTD. | 2006-10-05 | — | — | US | claimed |
| WO-2006070396-A1 | PROCESS FOR PRODUCING 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON2-YL)METHYL] PIPERIDINE OR ITS SALT THEREOF VIA NOVEL INTERMEDIATE | JUBILANT ORGANOSYS LIMITED (IN) | 2006-07-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137812-A1 | PROCESS FOR PRODUCING 1-BENZYL-4-[5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE OR ITS SALT THEREOF VIA NOVEL INTERMEDIATE | TET2, DHPS, AZI2 | OPRM1 1184/4885DRD3 1436/4885DRD2 599/4885 |
| US-20190127311-A1 | C-HALOGEN BOND FORMATION | CBR3, FOS, CBR1 | OPRM1 3199/4885DRD3 246/4885DRD2 969/4885 |
| US-20060224016-A1 | Process for preparing 3-aminophenylacetylenes | NAT1, NAT10, KAT7 | OPRM1 2808/4885DRD3 1429/4885DRD2 1671/4885 |
| US-20140249329-A1 | C-HALOGEN BOND FORMATION | CBR3, FOS, CBR1 | OPRM1 3199/4885DRD3 246/4885DRD2 969/4885 |
| US-10196341-B2 | C-halogen bond formation | CBR3, FOS, CBR1 | OPRM1 3199/4885DRD3 246/4885DRD2 969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.